How Safe Is the New Alzheimer’s Drug?

How Safe Is the New Alzheimer’s Drug?

By Duke University As new Alzheimer’s drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them, and whether they truly slow the disease outside tightly controlled studies. Researchers at Duke Health studied more than 230 patients treated with lecanemab, a new FDA-approved therapy (known as an anti-amyloid therapy) designed to remove a protein linked to Alzheimer…